nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—SLC22A8—choroid plexus—malignant glioma	0.0913	0.256	CbGeAlD
Baclofen—Wound dehiscence—Carmustine—malignant glioma	0.0381	0.0713	CcSEcCtD
Baclofen—GABBR2—brainstem—malignant glioma	0.0363	0.102	CbGeAlD
Baclofen—GABBR2—telencephalon—malignant glioma	0.0322	0.0904	CbGeAlD
Baclofen—GABBR2—medulla oblongata—malignant glioma	0.0253	0.071	CbGeAlD
Baclofen—GABBR2—midbrain—malignant glioma	0.0231	0.0649	CbGeAlD
Baclofen—GABBR2—spinal cord—malignant glioma	0.0226	0.0633	CbGeAlD
Baclofen—Pneumonia aspiration—Carmustine—malignant glioma	0.0201	0.0377	CcSEcCtD
Baclofen—GABBR2—central nervous system—malignant glioma	0.0183	0.0514	CbGeAlD
Baclofen—GABBR2—cerebellum—malignant glioma	0.0179	0.0502	CbGeAlD
Baclofen—GABBR1—telencephalon—malignant glioma	0.0163	0.0456	CbGeAlD
Baclofen—GABBR2—brain—malignant glioma	0.0145	0.0408	CbGeAlD
Baclofen—GABBR1—medulla oblongata—malignant glioma	0.0128	0.0358	CbGeAlD
Baclofen—GABBR1—midbrain—malignant glioma	0.0117	0.0327	CbGeAlD
Baclofen—GABBR1—spinal cord—malignant glioma	0.0114	0.0319	CbGeAlD
Baclofen—Meningitis—Carmustine—malignant glioma	0.0113	0.0212	CcSEcCtD
Baclofen—Paranoid reaction—Carmustine—malignant glioma	0.0103	0.0193	CcSEcCtD
Baclofen—Personality disorder—Carmustine—malignant glioma	0.0102	0.019	CcSEcCtD
Baclofen—GABBR1—cerebellum—malignant glioma	0.00904	0.0253	CbGeAlD
Baclofen—Cerebral ischaemia—Temozolomide—malignant glioma	0.00879	0.0164	CcSEcCtD
Baclofen—Faecal incontinence—Carmustine—malignant glioma	0.00871	0.0163	CcSEcCtD
Baclofen—Faecal incontinence—Temozolomide—malignant glioma	0.00842	0.0157	CcSEcCtD
Baclofen—GABBR1—brain—malignant glioma	0.00734	0.0206	CbGeAlD
Baclofen—Deep vein thrombosis—Temozolomide—malignant glioma	0.00698	0.0131	CcSEcCtD
Baclofen—Paranoia—Carmustine—malignant glioma	0.00645	0.0121	CcSEcCtD
Baclofen—Digestion impaired—Temozolomide—malignant glioma	0.00636	0.0119	CcSEcCtD
Baclofen—Memory impairment—Temozolomide—malignant glioma	0.00541	0.0101	CcSEcCtD
Baclofen—Petechiae—Temozolomide—malignant glioma	0.00517	0.00966	CcSEcCtD
Baclofen—Speech disorder—Carmustine—malignant glioma	0.00511	0.00956	CcSEcCtD
Baclofen—Accidental injury—Carmustine—malignant glioma	0.00497	0.00929	CcSEcCtD
Baclofen—Speech disorder—Temozolomide—malignant glioma	0.00494	0.00924	CcSEcCtD
Baclofen—Chlorphenesin—BCHE—malignant glioma	0.00486	0.212	CrCbGaD
Baclofen—Thinking abnormal—Carmustine—malignant glioma	0.0048	0.00898	CcSEcCtD
Baclofen—Leukocytosis—Carmustine—malignant glioma	0.00468	0.00875	CcSEcCtD
Baclofen—Gait disturbance—Carmustine—malignant glioma	0.00451	0.00842	CcSEcCtD
Baclofen—Coordination abnormal—Carmustine—malignant glioma	0.00448	0.00837	CcSEcCtD
Baclofen—Pulmonary embolism—Carmustine—malignant glioma	0.0044	0.00822	CcSEcCtD
Baclofen—Gait disturbance—Temozolomide—malignant glioma	0.00435	0.00814	CcSEcCtD
Baclofen—Respiratory failure—Temozolomide—malignant glioma	0.00433	0.00809	CcSEcCtD
Baclofen—Coordination abnormal—Temozolomide—malignant glioma	0.00433	0.00809	CcSEcCtD
Baclofen—Ibuprofen—BCL2—malignant glioma	0.00428	0.187	CrCbGaD
Baclofen—Pulmonary embolism—Temozolomide—malignant glioma	0.00425	0.00794	CcSEcCtD
Baclofen—Vaginal inflammation—Temozolomide—malignant glioma	0.00425	0.00794	CcSEcCtD
Baclofen—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00425	0.00794	CcSEcCtD
Baclofen—Urinary incontinence—Carmustine—malignant glioma	0.00425	0.00794	CcSEcCtD
Baclofen—Urinary incontinence—Temozolomide—malignant glioma	0.0041	0.00767	CcSEcCtD
Baclofen—Coma—Carmustine—malignant glioma	0.00402	0.00751	CcSEcCtD
Baclofen—Vaginal infection—Temozolomide—malignant glioma	0.00401	0.0075	CcSEcCtD
Baclofen—Abnormal vision—Carmustine—malignant glioma	0.00383	0.00717	CcSEcCtD
Baclofen—Mental disability—Carmustine—malignant glioma	0.00382	0.00713	CcSEcCtD
Baclofen—Sepsis—Carmustine—malignant glioma	0.00382	0.00713	CcSEcCtD
Baclofen—Abnormal vision—Temozolomide—malignant glioma	0.00371	0.00693	CcSEcCtD
Baclofen—Mental disability—Temozolomide—malignant glioma	0.00369	0.00689	CcSEcCtD
Baclofen—Thrombophlebitis—Carmustine—malignant glioma	0.00369	0.00689	CcSEcCtD
Baclofen—SLC22A8—central nervous system—malignant glioma	0.00365	0.0102	CbGeAlD
Baclofen—Swelling—Carmustine—malignant glioma	0.00362	0.00676	CcSEcCtD
Baclofen—Thrombophlebitis—Temozolomide—malignant glioma	0.00356	0.00666	CcSEcCtD
Baclofen—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00355	0.00663	CcSEcCtD
Baclofen—Gastroenteritis—Temozolomide—malignant glioma	0.00348	0.00651	CcSEcCtD
Baclofen—Injury—Carmustine—malignant glioma	0.00347	0.00649	CcSEcCtD
Baclofen—Ibuprofen—CXCL8—malignant glioma	0.00343	0.15	CrCbGaD
Baclofen—Amnesia—Carmustine—malignant glioma	0.0034	0.00635	CcSEcCtD
Baclofen—Nasal congestion—Temozolomide—malignant glioma	0.00339	0.00633	CcSEcCtD
Baclofen—Amnesia—Temozolomide—malignant glioma	0.00328	0.00614	CcSEcCtD
Baclofen—Diplopia—Carmustine—malignant glioma	0.00319	0.00597	CcSEcCtD
Baclofen—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00319	0.00597	CcSEcCtD
Baclofen—Diplopia—Temozolomide—malignant glioma	0.00308	0.00577	CcSEcCtD
Baclofen—Face oedema—Carmustine—malignant glioma	0.00308	0.00576	CcSEcCtD
Baclofen—Affect lability—Temozolomide—malignant glioma	0.00304	0.00568	CcSEcCtD
Baclofen—Ataxia—Carmustine—malignant glioma	0.003	0.00561	CcSEcCtD
Baclofen—Face oedema—Temozolomide—malignant glioma	0.00298	0.00557	CcSEcCtD
Baclofen—Chlorpropamide—PTGS1—malignant glioma	0.00297	0.13	CrCbGaD
Baclofen—Mood swings—Temozolomide—malignant glioma	0.00292	0.00546	CcSEcCtD
Baclofen—Ataxia—Temozolomide—malignant glioma	0.0029	0.00542	CcSEcCtD
Baclofen—SLC22A8—brain—malignant glioma	0.0029	0.00813	CbGeAlD
Baclofen—Dehydration—Temozolomide—malignant glioma	0.00287	0.00536	CcSEcCtD
Baclofen—Muscular weakness—Carmustine—malignant glioma	0.00282	0.00526	CcSEcCtD
Baclofen—Breast disorder—Temozolomide—malignant glioma	0.00279	0.00521	CcSEcCtD
Baclofen—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00278	0.00519	CcSEcCtD
Baclofen—Dysphagia—Carmustine—malignant glioma	0.00276	0.00516	CcSEcCtD
Baclofen—Muscular weakness—Temozolomide—malignant glioma	0.00272	0.00509	CcSEcCtD
Baclofen—Dysphagia—Temozolomide—malignant glioma	0.00267	0.00498	CcSEcCtD
Baclofen—Sweating increased—Temozolomide—malignant glioma	0.0026	0.00486	CcSEcCtD
Baclofen—Dysuria—Temozolomide—malignant glioma	0.00249	0.00466	CcSEcCtD
Baclofen—Hyperglycaemia—Carmustine—malignant glioma	0.00249	0.00465	CcSEcCtD
Baclofen—Pneumonia—Carmustine—malignant glioma	0.00247	0.00463	CcSEcCtD
Baclofen—Pollakiuria—Temozolomide—malignant glioma	0.00246	0.0046	CcSEcCtD
Baclofen—Erectile dysfunction—Temozolomide—malignant glioma	0.00246	0.00459	CcSEcCtD
Baclofen—Depression—Carmustine—malignant glioma	0.00245	0.00459	CcSEcCtD
Baclofen—Weight increased—Temozolomide—malignant glioma	0.00243	0.00454	CcSEcCtD
Baclofen—Renal failure—Carmustine—malignant glioma	0.00242	0.00452	CcSEcCtD
Baclofen—Weight decreased—Temozolomide—malignant glioma	0.00241	0.00451	CcSEcCtD
Baclofen—Hyperglycaemia—Temozolomide—malignant glioma	0.0024	0.0045	CcSEcCtD
Baclofen—Pneumonia—Temozolomide—malignant glioma	0.00239	0.00447	CcSEcCtD
Baclofen—Depression—Temozolomide—malignant glioma	0.00237	0.00443	CcSEcCtD
Baclofen—Ibuprofen—PPARG—malignant glioma	0.00237	0.103	CrCbGaD
Baclofen—Hepatobiliary disease—Temozolomide—malignant glioma	0.00225	0.0042	CcSEcCtD
Baclofen—Chlorphenesin—PTGS2—malignant glioma	0.00224	0.0979	CrCbGaD
Baclofen—Hypoaesthesia—Carmustine—malignant glioma	0.0022	0.00411	CcSEcCtD
Baclofen—Hallucination—Carmustine—malignant glioma	0.0022	0.00411	CcSEcCtD
Baclofen—Oedema peripheral—Carmustine—malignant glioma	0.00218	0.00407	CcSEcCtD
Baclofen—Connective tissue disorder—Carmustine—malignant glioma	0.00217	0.00406	CcSEcCtD
Baclofen—Visual impairment—Carmustine—malignant glioma	0.00213	0.00398	CcSEcCtD
Baclofen—Hallucination—Temozolomide—malignant glioma	0.00212	0.00397	CcSEcCtD
Baclofen—Hypoaesthesia—Temozolomide—malignant glioma	0.00212	0.00397	CcSEcCtD
Baclofen—Urinary tract disorder—Temozolomide—malignant glioma	0.00211	0.00394	CcSEcCtD
Baclofen—Oedema peripheral—Temozolomide—malignant glioma	0.0021	0.00393	CcSEcCtD
Baclofen—Connective tissue disorder—Temozolomide—malignant glioma	0.0021	0.00392	CcSEcCtD
Baclofen—Urethral disorder—Temozolomide—malignant glioma	0.00209	0.00391	CcSEcCtD
Baclofen—Eye disorder—Carmustine—malignant glioma	0.00206	0.00386	CcSEcCtD
Baclofen—Visual impairment—Temozolomide—malignant glioma	0.00206	0.00384	CcSEcCtD
Baclofen—Flushing—Carmustine—malignant glioma	0.00205	0.00383	CcSEcCtD
Baclofen—Eye disorder—Temozolomide—malignant glioma	0.00199	0.00373	CcSEcCtD
Baclofen—Tinnitus—Temozolomide—malignant glioma	0.00199	0.00372	CcSEcCtD
Baclofen—Flushing—Temozolomide—malignant glioma	0.00198	0.0037	CcSEcCtD
Baclofen—Cardiac disorder—Temozolomide—malignant glioma	0.00198	0.0037	CcSEcCtD
Baclofen—Arrhythmia—Carmustine—malignant glioma	0.00197	0.00369	CcSEcCtD
Baclofen—Alopecia—Carmustine—malignant glioma	0.00195	0.00365	CcSEcCtD
Baclofen—Angiopathy—Temozolomide—malignant glioma	0.00194	0.00362	CcSEcCtD
Baclofen—Mental disorder—Carmustine—malignant glioma	0.00193	0.00362	CcSEcCtD
Baclofen—Mediastinal disorder—Temozolomide—malignant glioma	0.00192	0.0036	CcSEcCtD
Baclofen—Malnutrition—Carmustine—malignant glioma	0.00192	0.00359	CcSEcCtD
Baclofen—Chills—Temozolomide—malignant glioma	0.00191	0.00358	CcSEcCtD
Baclofen—Alopecia—Temozolomide—malignant glioma	0.00189	0.00353	CcSEcCtD
Baclofen—Mental disorder—Temozolomide—malignant glioma	0.00187	0.0035	CcSEcCtD
Baclofen—Back pain—Carmustine—malignant glioma	0.00186	0.00348	CcSEcCtD
Baclofen—Malnutrition—Temozolomide—malignant glioma	0.00186	0.00347	CcSEcCtD
Baclofen—Dysgeusia—Temozolomide—malignant glioma	0.00182	0.0034	CcSEcCtD
Baclofen—Vision blurred—Carmustine—malignant glioma	0.00181	0.00339	CcSEcCtD
Baclofen—Tremor—Carmustine—malignant glioma	0.0018	0.00337	CcSEcCtD
Baclofen—Back pain—Temozolomide—malignant glioma	0.0018	0.00336	CcSEcCtD
Baclofen—Anaemia—Carmustine—malignant glioma	0.00178	0.00332	CcSEcCtD
Baclofen—Agitation—Carmustine—malignant glioma	0.00177	0.0033	CcSEcCtD
Baclofen—Vision blurred—Temozolomide—malignant glioma	0.00175	0.00327	CcSEcCtD
Baclofen—Ibuprofen—PTGS1—malignant glioma	0.00175	0.0764	CrCbGaD
Baclofen—Tremor—Temozolomide—malignant glioma	0.00174	0.00325	CcSEcCtD
Baclofen—Ill-defined disorder—Temozolomide—malignant glioma	0.00172	0.00322	CcSEcCtD
Baclofen—Anaemia—Temozolomide—malignant glioma	0.00172	0.00321	CcSEcCtD
Baclofen—Agitation—Temozolomide—malignant glioma	0.00171	0.00319	CcSEcCtD
Baclofen—Malaise—Temozolomide—malignant glioma	0.00168	0.00313	CcSEcCtD
Baclofen—Vertigo—Temozolomide—malignant glioma	0.00167	0.00312	CcSEcCtD
Baclofen—Convulsion—Carmustine—malignant glioma	0.00167	0.00311	CcSEcCtD
Baclofen—Hypertension—Carmustine—malignant glioma	0.00166	0.0031	CcSEcCtD
Baclofen—Palpitations—Temozolomide—malignant glioma	0.00164	0.00307	CcSEcCtD
Baclofen—Chest pain—Carmustine—malignant glioma	0.00164	0.00306	CcSEcCtD
Baclofen—Myalgia—Carmustine—malignant glioma	0.00164	0.00306	CcSEcCtD
Baclofen—Anxiety—Carmustine—malignant glioma	0.00163	0.00305	CcSEcCtD
Baclofen—Convulsion—Temozolomide—malignant glioma	0.00161	0.00301	CcSEcCtD
Baclofen—Hypertension—Temozolomide—malignant glioma	0.0016	0.003	CcSEcCtD
Baclofen—Confusional state—Carmustine—malignant glioma	0.00158	0.00296	CcSEcCtD
Baclofen—Myalgia—Temozolomide—malignant glioma	0.00158	0.00296	CcSEcCtD
Baclofen—Anxiety—Temozolomide—malignant glioma	0.00158	0.00295	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00157	0.00294	CcSEcCtD
Baclofen—Oedema—Carmustine—malignant glioma	0.00157	0.00293	CcSEcCtD
Baclofen—Discomfort—Temozolomide—malignant glioma	0.00156	0.00292	CcSEcCtD
Baclofen—Infection—Carmustine—malignant glioma	0.00156	0.00291	CcSEcCtD
Baclofen—Dry mouth—Temozolomide—malignant glioma	0.00155	0.00289	CcSEcCtD
Baclofen—Tachycardia—Carmustine—malignant glioma	0.00153	0.00286	CcSEcCtD
Baclofen—Confusional state—Temozolomide—malignant glioma	0.00153	0.00286	CcSEcCtD
Baclofen—Oedema—Temozolomide—malignant glioma	0.00152	0.00283	CcSEcCtD
Baclofen—Infection—Temozolomide—malignant glioma	0.00151	0.00282	CcSEcCtD
Baclofen—Anorexia—Carmustine—malignant glioma	0.0015	0.0028	CcSEcCtD
Baclofen—Nervous system disorder—Temozolomide—malignant glioma	0.00149	0.00278	CcSEcCtD
Baclofen—Skin disorder—Temozolomide—malignant glioma	0.00147	0.00275	CcSEcCtD
Baclofen—Hypotension—Carmustine—malignant glioma	0.00147	0.00274	CcSEcCtD
Baclofen—Hyperhidrosis—Temozolomide—malignant glioma	0.00147	0.00274	CcSEcCtD
Baclofen—Anorexia—Temozolomide—malignant glioma	0.00145	0.0027	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00143	0.00267	CcSEcCtD
Baclofen—Insomnia—Carmustine—malignant glioma	0.00142	0.00265	CcSEcCtD
Baclofen—Paraesthesia—Carmustine—malignant glioma	0.00141	0.00263	CcSEcCtD
Baclofen—Dyspnoea—Carmustine—malignant glioma	0.0014	0.00261	CcSEcCtD
Baclofen—Somnolence—Carmustine—malignant glioma	0.00139	0.00261	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00138	0.00258	CcSEcCtD
Baclofen—Insomnia—Temozolomide—malignant glioma	0.00137	0.00256	CcSEcCtD
Baclofen—Decreased appetite—Carmustine—malignant glioma	0.00136	0.00255	CcSEcCtD
Baclofen—Paraesthesia—Temozolomide—malignant glioma	0.00136	0.00255	CcSEcCtD
Baclofen—Gastrointestinal disorder—Carmustine—malignant glioma	0.00135	0.00253	CcSEcCtD
Baclofen—Dyspnoea—Temozolomide—malignant glioma	0.00135	0.00253	CcSEcCtD
Baclofen—Somnolence—Temozolomide—malignant glioma	0.00135	0.00252	CcSEcCtD
Baclofen—Pain—Carmustine—malignant glioma	0.00134	0.00251	CcSEcCtD
Baclofen—Constipation—Carmustine—malignant glioma	0.00134	0.00251	CcSEcCtD
Baclofen—Dyspepsia—Temozolomide—malignant glioma	0.00133	0.00249	CcSEcCtD
Baclofen—Decreased appetite—Temozolomide—malignant glioma	0.00132	0.00246	CcSEcCtD
Baclofen—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00131	0.00245	CcSEcCtD
Baclofen—Fatigue—Temozolomide—malignant glioma	0.00131	0.00244	CcSEcCtD
Baclofen—Pain—Temozolomide—malignant glioma	0.0013	0.00242	CcSEcCtD
Baclofen—Constipation—Temozolomide—malignant glioma	0.0013	0.00242	CcSEcCtD
Baclofen—Feeling abnormal—Carmustine—malignant glioma	0.00129	0.00242	CcSEcCtD
Baclofen—Gastrointestinal pain—Carmustine—malignant glioma	0.00128	0.0024	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—CCR4—malignant glioma	0.00127	0.0149	CbGpPWpGaD
Baclofen—Feeling abnormal—Temozolomide—malignant glioma	0.00125	0.00234	CcSEcCtD
Baclofen—Abdominal pain—Carmustine—malignant glioma	0.00124	0.00232	CcSEcCtD
Baclofen—Body temperature increased—Carmustine—malignant glioma	0.00124	0.00232	CcSEcCtD
Baclofen—Gastrointestinal pain—Temozolomide—malignant glioma	0.00124	0.00232	CcSEcCtD
Baclofen—GABBR2—Neuronal System—SLC6A3—malignant glioma	0.00121	0.0142	CbGpPWpGaD
Baclofen—Urticaria—Temozolomide—malignant glioma	0.0012	0.00225	CcSEcCtD
Baclofen—Abdominal pain—Temozolomide—malignant glioma	0.0012	0.00224	CcSEcCtD
Baclofen—Body temperature increased—Temozolomide—malignant glioma	0.0012	0.00224	CcSEcCtD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.00114	0.0134	CbGpPWpGaD
Baclofen—Asthenia—Carmustine—malignant glioma	0.00113	0.0021	CcSEcCtD
Baclofen—Asthenia—Temozolomide—malignant glioma	0.00109	0.00203	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—LATS2—malignant glioma	0.00109	0.0127	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—BCHE—malignant glioma	0.00108	0.0127	CbGpPWpGaD
Baclofen—Diarrhoea—Carmustine—malignant glioma	0.00107	0.00201	CcSEcCtD
Baclofen—Pruritus—Temozolomide—malignant glioma	0.00107	0.00201	CcSEcCtD
Baclofen—Dizziness—Carmustine—malignant glioma	0.00104	0.00194	CcSEcCtD
Baclofen—Diarrhoea—Temozolomide—malignant glioma	0.00104	0.00194	CcSEcCtD
Baclofen—GABBR1—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.00102	0.0119	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—CXCR3—malignant glioma	0.00101	0.0118	CbGpPWpGaD
Baclofen—Dizziness—Temozolomide—malignant glioma	0.001	0.00187	CcSEcCtD
Baclofen—Ibuprofen—PTGS2—malignant glioma	0.001	0.0437	CrCbGaD
Baclofen—Vomiting—Carmustine—malignant glioma	0.000997	0.00186	CcSEcCtD
Baclofen—Rash—Carmustine—malignant glioma	0.000989	0.00185	CcSEcCtD
Baclofen—Dermatitis—Carmustine—malignant glioma	0.000988	0.00185	CcSEcCtD
Baclofen—Headache—Carmustine—malignant glioma	0.000983	0.00184	CcSEcCtD
Baclofen—Vomiting—Temozolomide—malignant glioma	0.000964	0.0018	CcSEcCtD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000958	0.0112	CbGpPWpGaD
Baclofen—Rash—Temozolomide—malignant glioma	0.000956	0.00179	CcSEcCtD
Baclofen—Dermatitis—Temozolomide—malignant glioma	0.000955	0.00179	CcSEcCtD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000954	0.0112	CbGpPWpGaD
Baclofen—Headache—Temozolomide—malignant glioma	0.00095	0.00178	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—CXCR3—malignant glioma	0.000945	0.0111	CbGpPWpGaD
Baclofen—Nausea—Carmustine—malignant glioma	0.000932	0.00174	CcSEcCtD
Baclofen—GABBR1—G alpha (i) signalling events—BDKRB2—malignant glioma	0.00092	0.0108	CbGpPWpGaD
Baclofen—Nausea—Temozolomide—malignant glioma	0.000901	0.00168	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—BDKRB2—malignant glioma	0.000864	0.0101	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000859	0.0101	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—APOD—malignant glioma	0.000848	0.00993	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—KNG1—malignant glioma	0.000837	0.00979	CbGpPWpGaD
Baclofen—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.000836	0.00977	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—BCHE—malignant glioma	0.000831	0.00972	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—LATS1—malignant glioma	0.000823	0.00963	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CCR4—malignant glioma	0.000819	0.00959	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—KNG1—malignant glioma	0.000786	0.0092	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—SLC6A3—malignant glioma	0.000781	0.00914	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000736	0.00861	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.00072	0.00842	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CCR4—malignant glioma	0.000719	0.00841	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000717	0.00839	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LATS2—malignant glioma	0.0007	0.00819	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—BRAF—malignant glioma	0.000658	0.0077	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CCR4—malignant glioma	0.000653	0.00763	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000617	0.00722	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000615	0.00719	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CXCR3—malignant glioma	0.000609	0.00712	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—CXCL8—malignant glioma	0.000592	0.00692	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—BDKRB2—malignant glioma	0.000557	0.00652	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MDK—malignant glioma	0.000556	0.00651	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000554	0.00649	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000554	0.00648	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—MDM2—malignant glioma	0.000552	0.00645	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—RAF1—malignant glioma	0.00055	0.00643	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CXCR3—malignant glioma	0.000534	0.00625	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—DTX1—malignant glioma	0.000531	0.00621	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LATS1—malignant glioma	0.000531	0.00621	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—F2—malignant glioma	0.000508	0.00595	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000507	0.00593	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—KNG1—malignant glioma	0.000507	0.00593	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—BDKRB2—malignant glioma	0.000488	0.00571	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CXCR3—malignant glioma	0.000485	0.00567	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000464	0.00543	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CCR4—malignant glioma	0.000463	0.00542	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000462	0.00541	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—KNG1—malignant glioma	0.000444	0.0052	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—BDKRB2—malignant glioma	0.000444	0.00519	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000443	0.00518	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—APOD—malignant glioma	0.000431	0.00504	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—BRAF—malignant glioma	0.000424	0.00496	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SUFU—malignant glioma	0.000421	0.00493	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCR4—malignant glioma	0.000421	0.00492	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HEY2—malignant glioma	0.000416	0.00487	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GFAP—malignant glioma	0.000407	0.00476	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—KNG1—malignant glioma	0.000404	0.00472	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000399	0.00467	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SPHK1—malignant glioma	0.000393	0.0046	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCR4—malignant glioma	0.000385	0.00451	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HEY1—malignant glioma	0.000385	0.00451	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—CXCL8—malignant glioma	0.000381	0.00446	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00038	0.00444	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HIST1H3B—malignant glioma	0.000375	0.00438	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MDK—malignant glioma	0.000358	0.00419	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CXCL8—malignant glioma	0.000358	0.00419	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MMP3—malignant glioma	0.000358	0.00418	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—MDM2—malignant glioma	0.000355	0.00416	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—RAF1—malignant glioma	0.000354	0.00414	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CXCR3—malignant glioma	0.000344	0.00403	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—JAG2—malignant glioma	0.000342	0.004	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DTX1—malignant glioma	0.000342	0.004	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—F2—malignant glioma	0.000328	0.00383	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—BDKRB2—malignant glioma	0.000315	0.00368	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CXCR3—malignant glioma	0.000313	0.00366	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—H3F3A—malignant glioma	0.000289	0.00338	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—F2—malignant glioma	0.000287	0.00336	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCR3—malignant glioma	0.000287	0.00335	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—KNG1—malignant glioma	0.000286	0.00335	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—BDKRB2—malignant glioma	0.000286	0.00334	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—YWHAE—malignant glioma	0.000279	0.00326	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NTRK2—malignant glioma	0.000279	0.00326	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FLT1—malignant glioma	0.000277	0.00325	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—DUSP6—malignant glioma	0.000276	0.00323	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CG—malignant glioma	0.000275	0.00322	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—JAG1—malignant glioma	0.000273	0.00319	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NOTCH3—malignant glioma	0.000272	0.00318	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SUFU—malignant glioma	0.000272	0.00318	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HEY2—malignant glioma	0.000268	0.00314	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FBXW7—malignant glioma	0.000267	0.00313	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GFAP—malignant glioma	0.000262	0.00307	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—BDKRB2—malignant glioma	0.000262	0.00307	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—F2—malignant glioma	0.000261	0.00305	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—KNG1—malignant glioma	0.00026	0.00304	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SPHK1—malignant glioma	0.000254	0.00297	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AKT2—malignant glioma	0.000252	0.00294	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CG—malignant glioma	0.00025	0.00292	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HEY1—malignant glioma	0.000248	0.00291	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCR4—malignant glioma	0.000248	0.00291	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PTPN11—malignant glioma	0.000245	0.00287	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NOTCH2—malignant glioma	0.000244	0.00285	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CD—malignant glioma	0.000242	0.00283	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HIST1H3B—malignant glioma	0.000241	0.00282	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KNG1—malignant glioma	0.000238	0.00279	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CXCL8—malignant glioma	0.000231	0.0027	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MMP3—malignant glioma	0.00023	0.0027	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AKT2—malignant glioma	0.000228	0.00267	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NTRK1—malignant glioma	0.000227	0.00266	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000221	0.00258	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—JAG2—malignant glioma	0.00022	0.00258	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CD—malignant glioma	0.000219	0.00257	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MMP3—malignant glioma	0.000211	0.00247	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CB—malignant glioma	0.000211	0.00246	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CDKN2B—malignant glioma	0.000209	0.00245	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTK2—malignant glioma	0.000203	0.00238	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000203	0.00237	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CXCL8—malignant glioma	0.000202	0.00237	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HES1—malignant glioma	0.0002	0.00234	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NCOR1—malignant glioma	0.000199	0.00232	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—RAF1—malignant glioma	0.000196	0.00229	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—IL2—malignant glioma	0.000193	0.00226	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000193	0.00226	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CB—malignant glioma	0.000191	0.00224	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PDGFRA—malignant glioma	0.00019	0.00222	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—H3F3A—malignant glioma	0.000186	0.00218	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—F2—malignant glioma	0.000185	0.00217	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SPP1—malignant glioma	0.000185	0.00216	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCR3—malignant glioma	0.000185	0.00216	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CXCL8—malignant glioma	0.000184	0.00215	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—YWHAE—malignant glioma	0.00018	0.0021	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NTRK2—malignant glioma	0.00018	0.0021	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FLT1—malignant glioma	0.000179	0.00209	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DUSP6—malignant glioma	0.000178	0.00208	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000177	0.00207	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—JAG1—malignant glioma	0.000176	0.00206	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL2—malignant glioma	0.000176	0.00205	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NOTCH3—malignant glioma	0.000175	0.00205	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TERT—malignant glioma	0.000175	0.00205	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FBXW7—malignant glioma	0.000172	0.00201	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PDGFB—malignant glioma	0.000171	0.002	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGFR1—malignant glioma	0.00017	0.00199	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—BDKRB2—malignant glioma	0.000169	0.00198	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—F2—malignant glioma	0.000168	0.00197	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HIF1A—malignant glioma	0.000167	0.00196	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AKT2—malignant glioma	0.000162	0.0019	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CAV1—malignant glioma	0.000162	0.00189	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CG—malignant glioma	0.000161	0.00188	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KDR—malignant glioma	0.00016	0.00187	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PTPN11—malignant glioma	0.000158	0.00185	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NOTCH2—malignant glioma	0.000157	0.00184	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000156	0.00182	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—F2—malignant glioma	0.000154	0.0018	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FN1—malignant glioma	0.000154	0.0018	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KNG1—malignant glioma	0.000154	0.0018	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—BAD—malignant glioma	0.000152	0.00178	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NOTCH1—malignant glioma	0.000151	0.00176	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CD80—malignant glioma	0.000148	0.00173	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CG—malignant glioma	0.000147	0.00173	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APC—malignant glioma	0.000147	0.00173	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AKT2—malignant glioma	0.000147	0.00172	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NTRK1—malignant glioma	0.000146	0.00171	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EGF—malignant glioma	0.000146	0.00171	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTPN11—malignant glioma	0.000145	0.00169	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CD—malignant glioma	0.000141	0.00165	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—BRAF—malignant glioma	0.000139	0.00162	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MMP3—malignant glioma	0.000136	0.00159	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000136	0.00159	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKT2—malignant glioma	0.000135	0.00158	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDKN2B—malignant glioma	0.000135	0.00158	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—EGFR—malignant glioma	0.000134	0.00157	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTK2—malignant glioma	0.000131	0.00153	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CXCL8—malignant glioma	0.00013	0.00153	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CD—malignant glioma	0.00013	0.00152	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HES1—malignant glioma	0.000129	0.00151	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CA—malignant glioma	0.000128	0.0015	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NCOR1—malignant glioma	0.000128	0.0015	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—KRAS—malignant glioma	0.000127	0.00148	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—RAF1—malignant glioma	0.000126	0.00148	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—IL2—malignant glioma	0.000125	0.00146	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGF2—malignant glioma	0.000124	0.00145	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CB—malignant glioma	0.000123	0.00144	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDGFRA—malignant glioma	0.000123	0.00143	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SPP1—malignant glioma	0.000119	0.00139	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CXCL8—malignant glioma	0.000118	0.00139	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CA—malignant glioma	0.000117	0.00136	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MDM2—malignant glioma	0.000116	0.00136	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RAF1—malignant glioma	0.000116	0.00135	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ERBB2—malignant glioma	0.000114	0.00134	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL2—malignant glioma	0.000113	0.00132	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CB—malignant glioma	0.000113	0.00132	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TERT—malignant glioma	0.000113	0.00132	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDGFB—malignant glioma	0.00011	0.00129	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGFR1—malignant glioma	0.00011	0.00128	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCL8—malignant glioma	0.000109	0.00127	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HIF1A—malignant glioma	0.000108	0.00126	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AKT1—malignant glioma	0.000105	0.00123	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CAV1—malignant glioma	0.000104	0.00122	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CASP3—malignant glioma	0.000104	0.00122	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL2—malignant glioma	0.000104	0.00121	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KDR—malignant glioma	0.000103	0.00121	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FN1—malignant glioma	9.93e-05	0.00116	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—F2—malignant glioma	9.93e-05	0.00116	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MMP9—malignant glioma	9.82e-05	0.00115	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—BAD—malignant glioma	9.81e-05	0.00115	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTEN—malignant glioma	9.76e-05	0.00114	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NOTCH1—malignant glioma	9.72e-05	0.00114	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AKT1—malignant glioma	9.53e-05	0.00111	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CD80—malignant glioma	9.52e-05	0.00111	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APC—malignant glioma	9.5e-05	0.00111	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CG—malignant glioma	9.5e-05	0.00111	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EGF—malignant glioma	9.39e-05	0.0011	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTPN11—malignant glioma	9.34e-05	0.00109	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—BRAF—malignant glioma	8.93e-05	0.00104	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VEGFA—malignant glioma	8.82e-05	0.00103	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—RAF1—malignant glioma	8.74e-05	0.00102	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STAT3—malignant glioma	8.73e-05	0.00102	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKT2—malignant glioma	8.69e-05	0.00102	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—EGFR—malignant glioma	8.66e-05	0.00101	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CD—malignant glioma	8.35e-05	0.000977	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CA—malignant glioma	8.27e-05	0.000968	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—KRAS—malignant glioma	8.18e-05	0.000957	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MYC—malignant glioma	8.11e-05	0.000949	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGF2—malignant glioma	8e-05	0.000936	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EGFR—malignant glioma	7.94e-05	0.000928	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CA—malignant glioma	7.51e-05	0.000879	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KRAS—malignant glioma	7.5e-05	0.000877	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MDM2—malignant glioma	7.48e-05	0.000875	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RAF1—malignant glioma	7.46e-05	0.000872	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ERBB2—malignant glioma	7.38e-05	0.000863	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CB—malignant glioma	7.28e-05	0.000852	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCL8—malignant glioma	7e-05	0.000819	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CA—malignant glioma	6.89e-05	0.000806	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AKT1—malignant glioma	6.76e-05	0.000791	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CASP3—malignant glioma	6.7e-05	0.000783	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL2—malignant glioma	6.69e-05	0.000782	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TP53—malignant glioma	6.66e-05	0.00078	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MMP9—malignant glioma	6.33e-05	0.00074	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTEN—malignant glioma	6.29e-05	0.000736	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AKT1—malignant glioma	6.14e-05	0.000718	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VEGFA—malignant glioma	5.68e-05	0.000665	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STAT3—malignant glioma	5.63e-05	0.000658	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKT1—malignant glioma	5.63e-05	0.000658	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MYC—malignant glioma	5.23e-05	0.000612	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EGFR—malignant glioma	5.11e-05	0.000598	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KRAS—malignant glioma	4.83e-05	0.000565	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CA—malignant glioma	4.44e-05	0.000519	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TP53—malignant glioma	4.29e-05	0.000502	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKT1—malignant glioma	3.63e-05	0.000424	CbGpPWpGaD
